Study of Oral PQR309 in Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alex Adjei
Mayo Clinic
Principal Investigator - Andreas Wicki
Basel University Hospital
Principal Investigator - Filip Janku
MD Anderson Cancer
Principal Investigator - Jordi Rodon
Vall d'Hebron University Hospital
Principal Investigator - Martin Forster
University College London Hospitals
Principal Investigator - Mateusz Opyrchal
Roswell Park Cancer Institute
Study Director - Sarah Bladgen
Chruchill Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- M.D. Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Mar 2019
- Primary completion
- 21 Mar 2019
- Completion
- 21 Mar 2019
- Last update posted
- 22 Mar 2019
- Registered enrollment
- 70
- Registry id
- NCT02483858
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.